Aphria Inc - CEO, Irwin Simon
CEO, Irwin Simon
Source: CNBC.com
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Aphria (TSX:APHA) subsidiary, ASG Pharma, has received EU GMP certification for cannabis production from the Malta Medicines Authority
  • The certification ensures a certain level of quality and regulation compliance in ASG’s cannabis production facility
  • ASG produces cannabis for medicinal purposes, as well as for testing, research and development
  • In other news, Aphria has announced the liquidation of its C$39 million promissory note from GA Opportunities, for approximately $26 million
  • Aphria is up 2.56 per cent, and is currently trading for $5.21 per share

Aphria (TSX:APHA) subsidiary, ASG Pharma, has received EU GMP certification for cannabis production from the Malta Medicines Authority.

European Union Good Manufacturing Practice (EU GMP), ensures that a medical manufacturer’s production process complies with regulation standards. In this case, the certification applies to the facilities and processes for ASG’s production of medicinal cannabis. 

The subsidiary produces cannabis for medicinal purposes, as well as for testing, research and development. ASG received its first medical cannabis import license for analytical testing and research in 2018. Subsequently, the company upgraded its lab facility. 

Now, ASG can ship finished dried cannabis flower and finished oil for medicinal and research use in permitted EU jurisdictions.

The high capacity of its EU GMP-certified lab will also provide extra space for other related activities. These include importing, processing, packaging and distributing the company’s cannabis products throughout Europe.

Aphria’s Chief Executive Officer, Irwin D Simon, welcomed the subsidiary’s certification.

“We are pleased to receive EU GMP certification for ASG in Malta. This is our third facility to achieve this milestone, which really speaks to the company’s commitment to quality.

“We remain excited about growth opportunities as this increases our ability to serve, and further strengthens Aphria’s leadership in the European Union,” he said. 

In other news, Aphria has announced the liquidation of its C$39 million promissory note from investment company, GA Opportunities Corp. The liquidation resulted in proceeds of approximately $26 million.

Aphria is up 2.56 per cent, and is trading for $5.21 per share as of 11:15am EDT.

More From The Market Herald

" RWB (CSE:RWB) launches new vape product

Red White & Bloom Brands (RWB) has signed an exclusive agreement to utilize Skybar’s vape technology and debuted a new product.

" SLANG (CSE:SLNG) appoints new CEO and Chair of the Board

SLANG (SLNG) has promoted John Moynan as the Chief Executive Officer and appointed Ruth Chun as the Chair of the Board, effective immediately.
Heritage Cannabis Holdings Corp. - CEO, David Schwede.

" Heritage Cannabis (CANN) begins U.S. operations

Heritage Cannabis Holdings Corp. (CANN) is beginning operations in Missouri, U.S., after receiving state approval.

" The Gummy Project (CSE: GUMY) to supply Gummy Products in Virgin Hotels

The Gummy Project (GUMY) received a purchase order from Virgin Hotels Chicago to become the supplier of Gummy Products for guest room mini-bars.